je.st
news
Tag: biopharmaceuticals
Polymer Vials offer safe packaging for biopharmaceuticals.
2015-02-12 14:31:18| Industrial Newsroom - All News for Today
Combining inner and outer layer of Cyclic Olefin Polymer with center polyamide layer, Gx MultiShell Vials offer safety in filling, transportation, storage, and administration of biopharmaceuticals. Vials have high level of oxygen impermeability, making them suitable for packaging reaction-sensitive parenterals. Three-layer structure also maximizes break resistance, while low protein absorption minimizes product losses and eliminates need to overfill vials.
Tags: offer
safe
packaging
polymer
Keryx Biopharmaceuticals Announces Results From Ferric Citrate Phase...
2014-11-15 20:32:22| Biotech - Topix.net
Keryx Biopharmaceuticals, Inc. today announced results from a 48-week Open Label Extension safety study in which Ferric Citrate demonstrated long-term safety and efficacy in dialysis-dependent chronic kidney disease patients with elevated serum phosphorus levels, or hyperphosphatemia. The OLE findings were presented as a late-breaking poster at the 2014 American Society of Nephrology's Kidney Week meeting in Philadelphia, PA.
Tags: results
phase
announces
citrate
Why Did Baupost Double Its Stake In Keryx Biopharmaceuticals?
2014-10-13 17:51:09| Biotech - Topix.net
When Baupost makes a buy , investors pay attention. That's because Seth Klarman and his fund have hit numerous 'homeruns,' like Micron Technology and Idenix Pharmaceuticals .
Tags: double
stake
biopharmaceuticals
keryx
Seth Klarman's The Baupost Group Buys eBay, SunEdison Semiconductor, Keryx Biopharmaceuticals, ...
2014-08-15 00:30:08| Trucking - Topix.net
Legendary value investor, hedge fund manager Seth Klarman just reported his second quarter portfolio.
Tags: group
ebay
buys
semiconductor
Provectus Biopharmaceuticals' PV-10 Data Show Exceptional Complete...
2014-05-15 14:08:55| Logistics - Topix.net
Provectus Biopharmaceuticals, Inc. , a development-stage oncology and dermatology biopharmaceutical company, announced today that data on its investigational agent PV-10 for intralesional treatment of locally advanced cutaneous melanoma will be featured in two presentations in the Poster Highlights Session, Melanoma/Skin Cancers, on June 2, 2014 ... (more)
Tags: show
data
complete
exceptional